Photon-counting CT (PCCT) effectively detects heart disease in high-risk patients, offering "significant benefit for people previously ineligible for noninvasive screening," researchers from the have reported in a study published on 20 June in Radiology.
The findings could help clinicians better diagnose heart disease and tailor patient care, lead author Dr. Muhammad Hagar, from the University of Freiburg in Germany, told AuntMinnieEurope.com.
"The results broaden the spectrum of patients who can benefit from noninvasive coronary CT angiography, offering a safer and less stressful experience for them," he said. "Moreover, if confirmed in other trials, it may change the current guidelines that don't recommend [coronary CT angiography] for high-risk individuals."
Coronary artery disease is the most common form of heart disease, according to Hagar and colleagues. Coronary CT angiography (CCTA) is effective for ruling the disease out in patients at low- or intermediate risk, but using it in a high-risk population is difficult because many of these patients have coronary calcifications or stents; the calcifications often look bigger than they actually are, translating to the overestimation of blocks and plaque in the heart vessels and false-positive results, according to Hagar.
But the advent of ultrahigh-resolution coronary CT angiography conducted with a PCCT scanner shows promise for changing the game, the investigators wrote. To confirm this, they conducted a study that included 68 patients and compared the diagnostic accuracy of ultra-high-resolution CCTA with the standard of care, which is invasive coronary angiography. Study participants had severe aortic valve stenosis.
The group found that ultrahigh-resolution CCTA was highly sensitive and specific for identifying coronary artery disease. It garnered an overall image quality score of 1.5 on a five-point scale (with 1 being excellent and 5 nondiagnostic).
|Performance of ultrahigh resolution CCTA with PCCT for detecting heart disease
|Stenosis of ≥ 50%
|Stenosis of ≥ 70%
|Positive predictive value
|Negative predictive value
PCCT shows promise for improving how patients at high-risk of heart disease are diagnosed, according to Hagar. He and his fellow researchers expect PCCT technology to enter mainstream clinical practice over the next decade, and plan to further investigate its diagnostic capability for other applications, such as cancer imaging.
"It appears that the spectrum of patients benefiting from undergoing noninvasive CCTA has been significantly broadened by photon-counting detector technology," Hagar said. "This is excellent news for these patients and the imaging community."
More research is needed, wrote Michelle Williams, MDchB, PhD, and David Newby, DM, PhD, both of the University of Edinburgh in Scotland, in an accompanying editorial.
"The use of PCCT scanners offers several potential advances for CT imaging," they wrote. "However, at present, we do not know which patients would benefit most from this technology or how best to use it in clinical practice."